查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446913

营养基因组学市场：按产品类型、应用和最终用户划分：2023-2032 年全球机会分析和产业预测

Nutrigenomics Market By Product Type, By Applications, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格

营养基因组学是对特定基因突变或多态性存在的研究，在大多数情况下，这仅意味着对特定疾病过程的易感性，而环境和行为因素的复杂性，例如个体化的营养摄入，可能可以预防这种情况。

营养基因体学是研究特定营养素和营养补充食品个体基因组成表现的影响。

营养基因组学市场-IMG1

肥胖、糖尿病和心血管疾病等慢性病盛行率的上升正在推动营养基因组学测试市场的成长。在过去的十年中，蛋白质组学、基因组学和代谢体学等组学技术迅速发展，并与先进的生物资讯学相结合，已广泛用于基于蛋白质途径的疾病识别。目前，营养基因组学研究结果在一定程度上被用于治疗与饮食因素有关的疾病，如糖尿病、癌症、肥胖等，显着扩大了营养基因组学检测市场规模。

营养基因组学测试结果的准确性和可靠性是许多消费者最关心的问题之一。直接面向消费者的测试，包括营养基因组学测试，有不同程度的证据来支持他们的主张。一些直接面向消费者的测试有更多的科学和临床资料来支持它们提供的信息，而其他测试则有更少的资料来支持它们。此外，临床界对于各种基因突变在导致疾病中所扮演的角色存在分歧，这也影响了测试的准确性和可靠性。此外，并非所有变异都会导致个体患有某种疾病或病症的风险，因此阴性结果并不能减轻个体患有特定疾病或病症的风险，客户必须了解这一点。对于同一疾病，相同的营养基因组学测试可能会给出不同的结果，因为不同的公司测试不同的变异。因此，客户在订购营养基因组学测试和解释结果时应自行判断。因此，营养基因组学测试结果不被认为准确可靠，进一步阻碍了整体需求。

运动营养基因体学是营养基因体学测试市场的另一个重要机会。因此，运动员寻求量身定制的饮食来改善他们的健康。运动员群体的个人化营养旨在透过针对个人遗传特征的饮食建议来优化健康、身体组成和运动表现。运动营养师和註册营养师长期以来擅长在一般饮食指南中添加付加的分析，以适应不同的运动人群。然而，一般的「一刀切」建议仍然存在。众所周知，遗传差异会影响营养物质和食品生物活性物质的吸收、代谢、摄取、利用和排泄，最终影响许多代谢途径。营养基因组学和营养遗传学是利用基因组资讯和基因测试技术来检查个体遗传差异在改变运动员对营养素和其他食品成分的反应中所起的作用的实验方法。儘管很少有随机对照试验来检验遗传变异对强效补充食品的影响，但有证据表明基因-饮食交互作用对影响运动和运动表现的营养状况生物标记的影响。 。这项基础构成了运动营养基因体学领域持续发展的基础。

COVID-19 大流行对营养基因组学测试市场的成长产生了重大影响。这次疫情为远端医疗引入了许多新用户，进一步增强了其相对于潜在竞争对手的优势。 COVID-19 大流行也推动了营养基因组学市场内进一步的产业整合和合作。此外，COVID-19 大流行以及由此产生的消费者行为和期望的变化促使各种传统远端医疗选项，我也被迫追求它。此外，COVID-19 大流行对远端医疗的认识、接受和利用产生了积极影响，提高了消费者对虚拟护理的接受度。因此，大流行导致远距远端医疗服务的使用增加，预计这将推动大流行后时期的营养基因组市场。

从事银行网路安全市场的公司包括 Ancestry、Nutrigenomix、23andMe Inc.、DNAfit、GX Sciences Inc.、Xcode Life、Koninklijke DSM NV (Royal DSM)、 BASF SE、Danone SA、The Gene Box 等。

相关人员的主要利益

  • 本报告定量分析了 2022 年至 2032 年营养基因组学市场分析的细分市场、当前趋势、估计趋势和动态，并确定了一般营养基因组学市场机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的业务决策并加强供应商和买家网路。
  • 营养基因组市场区隔的详细分析有助于确定市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前位置的清晰了解。
  • 它包括区域和全球营养基因组学市场趋势、主要企业、细分市场、应用领域、市场成长策略等的分析。

可以使用此报告进行定制

  • 消费者购买行为分析
  • 最终用户偏好和痛点
  • 投资机会
  • 按地区分類的新参与企业
  • 科技趋势分析
  • 打入市场策略
  • 按产品/细分市场区隔
  • 痛点分析
  • 监管指引
  • 策略建议
  • 针对客户兴趣的其他公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 十字交叉细分市场分析 - 市场规模与预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 全球/区域/国家层级参与者的市场占有率分析
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 市场占有率分析
  • 品牌占有率分析
  • 价值链分析
  • 监管指引
  • 关键监管分析

第四章营养基因体学市场：依产品类型

  • 概述
  • 试剂和套件
  • 服务

第五章营养基因体学市场，依应用

  • 概述
  • 肥胖
  • 糖尿病
  • 心血管疾病
  • 癌症研究

第六章营养基因组学市场：依最终用户分类

  • 概述
  • 网路平台
  • 医院和诊所
  • 其他的

第七章营养基因体学市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • UAE
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第九章 公司简介

  • Cura Integrative Medicine
  • Holistic Health
  • Metagenics, Inc.
  • GX Sciences Inc.
  • The Gene Box
  • Nutrigenomix Inc.
  • Xcode Life
  • DNA Life
  • Interleukin Genetics
  • Genova Diagnostics
Product Code: A129082

Nutrigenetics studies the presence of a particular gene variant or polymorphism that in most cases merely connotes a predisposition to a particular disease process that may be prevented through a complex interplay of environmental and behavioral factors such as a personalized nutrition. Nutrigenomics refers to the study of the effects of specific nutrients or nutraceuticals on the expression of an individual's genetic makeup.

Nutrigenomics Market - IMG1

Rising prevalence of chronic diseases such as obesity, diabetes, and cardiovascular diseases is driving the growth of the nutrigenomics testing market. Over the past decade, rapid advancements in omic technologies such as proteomics, genomics, and metabolomics are combining with advanced bioinformatics to be broadly used for identifying diseases based on protein pathways. Currently, the findings of nutrigenomics have been used to some extent to treat diseases with a diet component like diabetes, cancer, and obesity, significantly boosting the nutrigenomics testing market size.

Accuracy and reliability of the nutrigenomic test findings is one of the major concerns for most of the consumers. Direct-to-consumer tests including nutrigenomic tests have varying levels of evidence that support their claims. Some direct-to-consumer tests have more scientific and clinical data to support the information provided in the test, while other tests do not have as much supporting data. Furthermore, disagreements in the clinical community about the role that different genetic variants are contributing to the disease is another reason affecting the accuracy and reliability of the test. Moreover, not all variants contribute to an individual's risk of getting a disease or condition, so it is important that customers understand that a negative result does not mean that the individual is free from the risk of developing a particular disease or condition. As different companies test for the different set of variants, therefore the same nutrigenomics tests might provide different results for the same disease. Thus, customers need to use their own judgment while ordering and interpreting the results from nutrigenomic tests. Therefore, nutrigenomics test results are not considered as accurate and reliable, further hampering the overall demand.

Sport nutrigenomics is another significant opportunity for nutrigenomics testing market. Thus, athletes are looking for tailor-made diets for improving their health status. Personalized nutrition in athletic populations aims in optimizing health, body composition, and exercise performance by targeting dietary recommendations to an individual's genetic profile. Sport dietitians and nutritionists have long been skilled at placing additional analysis on the one-size-fits-all general population dietary guidelines to accommodate various sporting populations. However, generic 'one-size-fits-all' recommendations still remain. Genetic differences are known to impact absorption, metabolism, uptake, utilization, and excretion of nutrients and food bio actives, which ultimately affects a number of metabolic pathways. Nutrigenomics and nutrigenetics are experimental approaches that use genomic information and genetic testing technologies to examine the role of individual genetic differences in modifying an athlete's response to nutrients and other food components. Although there have been few randomized, controlled trials examining the effects of genetic variation on performance in response to an ergogenic aid, there is a growing foundation of research linking gene-diet interactions on biomarkers of nutritional status, which impact exercise and sport performance. This foundation forms the basis from which the field of sport nutrigenomics continues to develop.

The COVID-19 pandemic had significant impacts on the nutrigenomics testing market growth. The pandemic introduced many new users to telehealth and further reinforced its benefits to potential competitors. In turn, the COVID-19 pandemic has also driven additional industry consolidation or collaboration within the nutrigenomics market. Furthermore, the COVID-19 pandemic, and its resulting changes in consumer behavior and expectations, has also caused various traditional healthcare providers to evaluate and pursue telehealth options that can be paired with their in-person capabilities. Also, telehealth awareness, acceptance, and usage have been positively impacted by the COVID-19 pandemic, leading to increased consumer acceptance of virtual care. Thus, the pandemic led to an increase in the utilization of telehealth services, which is anticipated to boost the nutrigenomics market in the post-pandemic period.

Some of the companies operating in the cybersecurity in banking market are Ancestry, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life, Koninklijke DSM N.V. (Royal DSM), BASF SE, Danone S.A., and The Gene Box.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nutrigenomics market analysis from 2022 to 2032 to identify the prevailing nutrigenomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nutrigenomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nutrigenomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Consumer Buying Behavior Analysis
  • End user preferences and pain points
  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • Pain Point Analysis
  • Regulatory Guidelines
  • Strategic Recommedations
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Product Type

  • Reagents and Kits
  • Services

By Applications

  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research
  • Obesity

By End User

  • Online Platforms
  • Hospitals and Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cura Integrative Medicine
    • Holistic Health
    • Metagenics, Inc.
    • GX Sciences Inc.
    • The Gene Box
    • Nutrigenomix Inc.
    • Xcode Life
    • DNA Life
    • Interleukin Genetics
    • Genova Diagnostics

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Market Share Analysis
  • 3.6. Brand Share Analysis
  • 3.7. Value Chain Analysis
  • 3.8. Regulatory Guidelines
  • 3.9. Key Regulation Analysis

CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents and Kits
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Services
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Obesity
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Diabetes
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Cancer Research
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Online Platforms
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hospitals and Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product Type
    • 7.2.3. Market size and forecast, by Applications
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product Type
      • 7.2.5.1.2. Market size and forecast, by Applications
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product Type
      • 7.2.5.2.2. Market size and forecast, by Applications
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product Type
      • 7.2.5.3.2. Market size and forecast, by Applications
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product Type
    • 7.3.3. Market size and forecast, by Applications
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product Type
      • 7.3.5.1.2. Market size and forecast, by Applications
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. UK
      • 7.3.5.2.1. Market size and forecast, by Product Type
      • 7.3.5.2.2. Market size and forecast, by Applications
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. France
      • 7.3.5.3.1. Market size and forecast, by Product Type
      • 7.3.5.3.2. Market size and forecast, by Applications
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Market size and forecast, by Product Type
      • 7.3.5.4.2. Market size and forecast, by Applications
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Market size and forecast, by Product Type
      • 7.3.5.5.2. Market size and forecast, by Applications
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product Type
      • 7.3.5.6.2. Market size and forecast, by Applications
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product Type
    • 7.4.3. Market size and forecast, by Applications
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Product Type
      • 7.4.5.1.2. Market size and forecast, by Applications
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Product Type
      • 7.4.5.2.2. Market size and forecast, by Applications
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product Type
      • 7.4.5.3.2. Market size and forecast, by Applications
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Market size and forecast, by Product Type
      • 7.4.5.4.2. Market size and forecast, by Applications
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Market size and forecast, by Product Type
      • 7.4.5.5.2. Market size and forecast, by Applications
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product Type
      • 7.4.5.6.2. Market size and forecast, by Applications
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product Type
    • 7.5.3. Market size and forecast, by Applications
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product Type
      • 7.5.5.1.2. Market size and forecast, by Applications
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. UAE
      • 7.5.5.2.1. Market size and forecast, by Product Type
      • 7.5.5.2.2. Market size and forecast, by Applications
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Product Type
      • 7.5.5.3.2. Market size and forecast, by Applications
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. South Africa
      • 7.5.5.4.1. Market size and forecast, by Product Type
      • 7.5.5.4.2. Market size and forecast, by Applications
      • 7.5.5.4.3. Market size and forecast, by End User
      • 7.5.5.5. Rest of LAMEA
      • 7.5.5.5.1. Market size and forecast, by Product Type
      • 7.5.5.5.2. Market size and forecast, by Applications
      • 7.5.5.5.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cura Integrative Medicine
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
  • 9.2. Holistic Health
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
  • 9.3. Metagenics, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
  • 9.4. GX Sciences Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
  • 9.5. The Gene Box
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
  • 9.6. Nutrigenomix Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
  • 9.7. Xcode Life
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
  • 9.8. DNA Life
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
  • 9.9. Interleukin Genetics
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
  • 9.10. Genova Diagnostics
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. NUTRIGENOMICS MARKET FOR REAGENTS AND KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. NUTRIGENOMICS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 05. NUTRIGENOMICS MARKET FOR OBESITY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. NUTRIGENOMICS MARKET FOR DIABETES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. NUTRIGENOMICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. NUTRIGENOMICS MARKET FOR CANCER RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. NUTRIGENOMICS MARKET FOR ONLINE PLATFORMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NUTRIGENOMICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NUTRIGENOMICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NUTRIGENOMICS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 20. U.S. NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. CANADA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 23. CANADA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. UK NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. UK NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 36. UK NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. ITALY NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 45. ITALY NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. CHINA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. CHINA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 55. CHINA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. INDIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. INDIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 61. INDIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH KOREA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH KOREA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. UAE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 79. UAE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 80. UAE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. CURA INTEGRATIVE MEDICINE: KEY EXECUTIVES
  • TABLE 91. CURA INTEGRATIVE MEDICINE: COMPANY SNAPSHOT
  • TABLE 92. HOLISTIC HEALTH: KEY EXECUTIVES
  • TABLE 93. HOLISTIC HEALTH: COMPANY SNAPSHOT
  • TABLE 94. METAGENICS, INC.: KEY EXECUTIVES
  • TABLE 95. METAGENICS, INC.: COMPANY SNAPSHOT
  • TABLE 96. GX SCIENCES INC.: KEY EXECUTIVES
  • TABLE 97. GX SCIENCES INC.: COMPANY SNAPSHOT
  • TABLE 98. THE GENE BOX: KEY EXECUTIVES
  • TABLE 99. THE GENE BOX: COMPANY SNAPSHOT
  • TABLE 100. NUTRIGENOMIX INC.: KEY EXECUTIVES
  • TABLE 101. NUTRIGENOMIX INC.: COMPANY SNAPSHOT
  • TABLE 102. XCODE LIFE: KEY EXECUTIVES
  • TABLE 103. XCODE LIFE: COMPANY SNAPSHOT
  • TABLE 104. DNA LIFE: KEY EXECUTIVES
  • TABLE 105. DNA LIFE: COMPANY SNAPSHOT
  • TABLE 106. INTERLEUKIN GENETICS: KEY EXECUTIVES
  • TABLE 107. INTERLEUKIN GENETICS: COMPANY SNAPSHOT
  • TABLE 108. GENOVA DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 109. GENOVA DIAGNOSTICS: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. NUTRIGENOMICS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF NUTRIGENOMICS MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN NUTRIGENOMICS MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN NUTRIGENOMICS MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL NUTRIGENOMICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. REGULATORY GUIDELINES: NUTRIGENOMICS MARKET
  • FIGURE 12. IMPACT OF KEY REGULATION: NUTRIGENOMICS MARKET
  • FIGURE 13. NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR REAGENTS AND KITS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR OBESITY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR DIABETES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR CANCER RESEARCH, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. NUTRIGENOMICS MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR ONLINE PLATFORMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. NUTRIGENOMICS MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 26. U.S. NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. UK NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. FRANCE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SPAIN NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. ITALY NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. CHINA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. JAPAN NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH KOREA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. AUSTRALIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. BRAZIL NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. UAE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SAUDI ARABIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF LAMEA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: NUTRIGENOMICS MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022